Avitas Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Avitas Wealth Management's PFE Position: Q4 2024 in Review
Avitas Wealth Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 85,556 shares — an estimated $2.48M sold.
Avitas Wealth Management first reported a position in PFE in Q3 2020 and held it in 16 quarters. The position peaked at $6.91M in Q4 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Avitas Wealth Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Avitas Wealth Management sold 85,556 Pfizer shares in Q4 2024, an estimated $2.48M.
- Avitas Wealth Management first reported a position in Pfizer in Q3 2020 and held it in 16 quarters.
- Avitas Wealth Management's Pfizer position peaked at $6.91M in Q4 2021.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Avitas Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.